In responsive IBD there were increased numbers of TGFβ-1 immunoreactive cells but there was little difference in the proportion of cells expressing TGFβ-1 between active and quiescent disease (Fig. 6B,D). This evidence concerns the gene TGFB1 and inflammatory bowel disease.